New drug QRX-3 shows promise in slowing kidney decline in chronic patients
Disease control
Completed
This study tested a new drug, QRX-3, in 127 adults with chronic kidney disease stages 3 to 5. The drug aims to protect kidney cells and improve their function by boosting a natural cell helper called NAD. Over 12 months, researchers measured how fast kidney function declined in p…
Phase: PHASE2 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated May 17, 2026 13:56 UTC